BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17980691)

  • 1. Impaired growth plate function in bmp-6 null mice.
    Perry MJ; McDougall KE; Hou SC; Tobias JH
    Bone; 2008 Jan; 42(1):216-25. PubMed ID: 17980691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration.
    Plant A; Tobias JH
    J Bone Miner Res; 2002 May; 17(5):782-90. PubMed ID: 12009008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-induced osteogenesis in intact female mice lacking ERbeta.
    McDougall KE; Perry MJ; Gibson RL; Bright JM; Colley SM; Hodgin JB; Smithies O; Tobias JH
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E817-23. PubMed ID: 12217900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice rendered severely deficient in megakaryocytes through targeted gene deletion of the thrombopoietin receptor c-Mpl have a normal skeletal phenotype.
    Perry MJ; Redding KA; Alexander WS; Tobias JH
    Calcif Tissue Int; 2007 Sep; 81(3):224-31. PubMed ID: 17674074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions.
    Washio-Oikawa K; Nakamura T; Usui M; Yoneda M; Ezura Y; Ishikawa I; Nakashima K; Noda T; Yamamoto T; Noda M
    J Bone Miner Res; 2007 Aug; 22(8):1217-23. PubMed ID: 17451368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
    Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
    J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
    Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
    Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose estrogen-induced osteogenesis is decreased in aged RUNX2(+/-) mice.
    Jüttner KV; Perry MJ
    Bone; 2007 Jul; 41(1):25-32. PubMed ID: 17475575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: potential importance for cartilage breakdown and synovial hypertrophy.
    Bobacz K; Sunk IG; Hayer S; Amoyo L; Tohidast-Akrad M; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2008 Jan; 58(1):109-18. PubMed ID: 18163510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered hypertrophic chondrocyte kinetics in GDF-5 deficient murine tibial growth plates.
    Mikic B; Clark RT; Battaglia TC; Gaschen V; Hunziker EB
    J Orthop Res; 2004 May; 22(3):552-6. PubMed ID: 15099634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated hypertrophic chondrocyte kinetics in GDF-7 deficient murine tibial growth plates.
    Mikic B; Ferreira MP; Battaglia TC; Hunziker EB
    J Orthop Res; 2008 Jul; 26(7):986-90. PubMed ID: 18302280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes.
    Takahashi T; Morris EA; Trippel SB
    Int J Mol Med; 2007 Jul; 20(1):53-7. PubMed ID: 17549388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of membrane-bound steel factor results in osteopenia in mice.
    Lotinun S; Evans GL; Turner RT; Oursler MJ
    J Bone Miner Res; 2005 Apr; 20(4):644-52. PubMed ID: 15765184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of bone morphogenetic proteins (BMPs) 2, 4, 6, and 7 during induced heterotopic bone formation.
    McCullough KA; Waits CA; Garimella R; Tague SE; Sipe JB; Anderson HC
    J Orthop Res; 2007 Apr; 25(4):465-72. PubMed ID: 17262821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
    Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
    J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen impairs both longitudinal and cortical bone growth in young male rats.
    Karimian E; Chagin AS; Gjerde J; Heino T; Lien EA; Ohlsson C; Sävendahl L
    J Bone Miner Res; 2008 Aug; 23(8):1267-77. PubMed ID: 18348701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hind limb unloading and reloading on nitric oxide synthase expression and apoptosis of osteocytes and chondrocytes.
    Basso N; Heersche JN
    Bone; 2006 Oct; 39(4):807-14. PubMed ID: 16765658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats.
    Xian CJ; Howarth GS; Cool JC; Foster BK
    Bone; 2004 Sep; 35(3):739-49. PubMed ID: 15336611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice.
    Chagin AS; Lindberg MK; Andersson N; Moverare S; Gustafsson JA; Sävendahl L; Ohlsson C
    J Bone Miner Res; 2004 Jan; 19(1):72-7. PubMed ID: 14753739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methotrexate and folinic acid on skeletal growth in mice.
    Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA
    Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.